Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 614 | 983 | 1,009 | 967 | 1,026 |
| Operating Income | -614 | -983 | -1,009 | -967 | -1,026 |
| Interest Expense | 4 | 1 | 4 | 7 | 10 |
| Other Income | -3 | 1 | 3 | 3 | 4 |
| Pre-tax Income | -621 | -983 | -1,011 | -971 | -1,032 |
| Net Income Continuous | -621 | -983 | -1,011 | -971 | -1,032 |
| Net Income | $-618 | $-986 | $-1,011 | $-971 | $-1,032 |
| EPS Basic Total Ops | -0.27 | -0.44 | -0.45 | -0.43 | -0.35 |
| EPS Basic Continuous Ops | -0.28 | -0.44 | -0.45 | -0.43 | -0.34 |
| EPS Diluted Total Ops | -0.27 | -0.44 | -0.45 | -0.43 | -0.35 |
| EPS Diluted Continuous Ops | -0.28 | -0.44 | -0.45 | -0.43 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.44 | -0.45 | N/A | N/A |
| EBITDA(a) | $-614 | $-983 | $-1,009 | $-967 | $-1,026 |